Plus, news about Aclaris, OMERS Life Sciences, Draupnir Bio, Pharnext and Actuate:
SK Biopharmaceuticals licenses Full-Life’s radiopharma drug: The deal …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy drug
Share this article According to GlobalData’s company profile on Kalvista Pharmaceuticals, Bio-active prosthesis coating was a key innovation area identified from patents. Kalvista Pharmaceuticals‘s grant
Most of us know that smoking is unhealthy. Cigarette packets display shocking picture warnings of diseased lungs and rotting teeth. And we often hear in